MindSpire, the neurotech start-up dedicated to helping people regulate stress and unlock peak performance, has raised £850,000 in pre-seed funding. This investment will support the launch of MindSpire’s first device: SONA™, a medical-grade wearable that delivers precision-coded electrical pulses to the vagus nerve, activating brain circuits for calm, focus and enhanced learning.
The round was led by SFC Capital, with participation from SyndicateRoom and non-dilutive innovation funding secured via Innovate UK’s Investor Partnership Programme. The £850,000 investment will enable MindSpire, based at the London Institute for Healthcare Engineering (LIHE), to complete the development and launch of SONA™.
MindSpire exists to make advanced nervous system care not only effective for high performers but also meaningful for those who need it most. Early sales of SONA™ will continue to fund research into how the technology can relieve chronic stress in people facing real-world challenges such as anxiety, long COVID, trauma, burnout and frontline fatigue.
MindSpire was founded to address the impact of chronic stress on health. The start-up’s AI-driven platform combines vagus nerve stimulation with real-time personalisation to enhance cognitive function and emotional regulation, enabling users to optimise their mental states and improve focus, learning and resilience.
MindSpire’s breakthrough lies in the precision and personalisation of its stimulation. SONA™ delivers biologically-aligned electrical pulses from the outer ear to the brainstem, syncing with the brain’s natural rhythms. This is achieved through vagus nerve stimulation (taVNS), real-time HRV (Heart Rate Variability) sensing and sound. These precision-coded inputs rebalance autonomic tone, enhance neuroplasticity and support brain performance. Its companion platform, NeuroSphere™, uses AI to personalise stimulation based on each user’s data and goals. It is also supported by early clinical studies for the treatment of stress, tinnitus, Parkinson’s Disease and chronic pain.
MindSpire is now actively building strategic partnerships with health platforms and innovators in stress, sleep, longevity and performance. The team is also speaking with investors ahead of its next funding round.
